Skip to main content

Artificial Intelligence

By Mike Miliard | 12:21 pm | October 29, 2019
Genomic medicine researchers at the laboratory have been using artificial intelligence, developed as part of Microsoft's Project Hanover, to help manage the vast amount of research data needed to power its precision oncology initiatives.
By Nathan Eddy | 11:48 am | October 28, 2019
The leading-edge technology could provide vastly faster power and processing speeds, and enable fundamentally different algorithmic search and data homogenization strategies.
By Nathan Eddy | 01:37 pm | October 25, 2019
The two funds are the Artificial Intelligence and Digital Translation Fund, which boasts initial funding of $30 million over five years, and the Translational Innovation Fund, which will provide $50 million in funding over six years.
By Mike Miliard | 03:52 pm | October 24, 2019
The edge computing technology's neural network algorithms can help drive workflow efficiency, detect gaps in care and deliver real-time intelligent notifications to staff, the AI developers say.
By HIMSS TV | 12:37 pm | October 23, 2019
The Mayo Clinic's new 10-year partnership with Google Cloud aims to look for the next breakthroughs that diagnose and treat complex and serious illness or conditions more effectively, says CIO Cris Ross.
By Nathan Eddy | 12:16 pm | October 23, 2019
A new report from EY shows how health systems need to embrace AI, social, mobile, analytics, cloud and sensor technologies to unlock the potential of their data.
By Nathan Eddy | 02:00 am | October 23, 2019
Researchers will also focus on adapting existing clinical decision support methods from the acute care sector, collaborating with clinicians to understand reliable signs of patient deterioration.
By Mélisande Rouger | 01:00 am | October 23, 2019
Researchers at Utrecht University Medical Center (UMC) built a flagship AI infrastructure that can run any algorithms in clinical practice, regardless of vendor equipment.
By Max Sullivan | 02:46 pm | October 22, 2019
The technology examines vital signs and other biomarkers to predict the likelihood of infection up to 48 hours ahead of clinical suspicion.
SPONSORED
By Siemens Healthineers | 07:38 am | October 22, 2019
An interview with Dr Christoph Zindel, member of the Managing Board at Siemens Healthineers, responsible for the Imaging and Advanced Therapies business segments.